BRL 32872

Drug Profile

BRL 32872

Alternative Names: BRL 32872A; BRL 3287A

Latest Information Update: 28 Sep 1998

Price : $50

At a glance

  • Originator GlaxoSmithKline
  • Class Class III antiarrhythmics; Ischaemic heart disorder therapies
  • Mechanism of Action Calcium channel antagonists; Potassium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Angina pectoris; Arrhythmias

Most Recent Events

  • 28 Sep 1998 Discontinued in Arrhythmias in United Kingdom (PO)
  • 28 Sep 1998 Discontinued-Preclinical for Arrhythmias in France (Unknown route)
  • 28 Sep 1998 Discontinued-Preclinical for Arrhythmias in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top